Dr. Joshua Baker

Clinical Genetics (M.D.) Ann & Robert H Lurie Childrens Hospital Of Chicago NPI1134534597

Open Payments

Note

The following payment details are based on a national transparency program known as the Sunshine Act that collects and publishes information about financial relationships between the health care industry (i.e. drug and device manufactures) and providers. These relationships may involve payment to providers for things such as research, speaking engagment, travel, gifts etc. Not all of these payment involve monetary compensations and may include batering of drugs or devices.

Total Payment Worth

$10,120.00
from 10 payments in the last 6 years

Total Cash or Cash Equivalent

$10,060.00
from 8 payments in the last 6 years

Total In-kind Items & Services

$60.00
from 2 payments in the last 6 years

Nature of Payments

Last 6 Years
Chart will render here...

Yearly Breakdown

Chart will render here...

Payment Details

Date Payment Type Form of Payment Item/Service Payment Amount
08/16/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $3200.00 Details
Payment from Ultragenyx Pharmaceutical Inc.
Payment Record ID 848967491
04/19/2021 General (Non-Research) In-kind items and services Education $30.00 Details
Payment from Ultragenyx Pharmaceutical Inc.
Payment Record ID 848961027
09/24/2021 General (Non-Research) In-kind items and services Education $30.00 Details
Payment from Ultragenyx Pharmaceutical Inc.
Payment Record ID 848961023
03/26/2021 General (Non-Research) Cash or cash equivalent Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $125.00 Details
Payment from BioMarin Pharmaceutical Inc.
Payment Record ID 831399749
08/26/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $305.00 Details
Payment from Takeda Pharmaceuticals U.S.A., Inc.
Payment Record ID 819857931
06/04/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $2450.00 Details
Payment from Takeda Pharmaceuticals U.S.A., Inc.
Payment Record ID 819857929
04/01/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $1320.00 Details
Payment from Takeda Pharmaceuticals U.S.A., Inc.
Payment Record ID 819857927
12/20/2021 General (Non-Research) Cash or cash equivalent Honoraria $190.00 Details
Payment from Horizon Therapeutics plc
Payment Record ID 797071279
03/25/2021 General (Non-Research) Cash or cash equivalent Honoraria $950.00 Details
Payment from Horizon Therapeutics plc
Payment Record ID 797071275
09/30/2020 General (Non-Research) Cash or cash equivalent Honoraria $1520.00 Details
Payment from Horizon Therapeutics plc
Payment Record ID 721376877